November 21, 2024
- Our Services
- Platforms
- Target Solutions
- Technologies
- Service Types
- Our Science
- About Us
- Contact us
November 21, 2024
With a comprehensive selection of models we are committed to advancing your preclinical development programs in a timely and cost-effective manner. Our more recent and novel in vitro organoid service offerings, are unmatched, and allow you to take advantage of the most translatable 3D in vitro models on the market.
Our in vitro services include over 500 validated and well-characterized cell lines for drug response screening and, as the only CRO service provider of HUB organoids
Our ex vivo services feature a 3D platform for evaluating monotherapy and combination drug responses in patient tumors with endogenous immune cell populations intact.
Our suite of validated in vivo models includes the largest commercially available collection of PDX models and over 200 cell line-derived xenograft models
© 2024 Crown Bioscience. All Rights Reserved.
© 2024 Crown Bioscience. All Rights Reserved. Privacy Policy
2024-05-19
2023-01-23